These stocks have an unusual volume in today's session
By Mill Chart
Last update: May 3, 2024
Discover the stocks with unexpected trading volume in today's session on the US markets.
Today's unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| XBP | -3.67% | The trading volume of XBP EUROPE HOLDINGS INC (NASDAQ:XBP) today is 1.7M shares, which is considered unusual. The share price decreased by 3.67%. In comparison to the average daily volume of the last 50 days, the current volume is 319.0% above. This suggests a notable change in trading activity. |
| CETX | -3.33% | CEMTREX INC's (NASDAQ:CETX) traded a high volume of 1.52M shares. Shares are witnessing a downward movement, with a decrease of 3.33%. Today's trading volume is 203.0% above the average 50-day volume, indicating a significant deviation from the norm. |
| CNTX | 4.57% | So far 789.63K shares of CONTEXT THERAPEUTICS INC (NASDAQ:CNTX) have traded in today's session. The price of NASDAQ:CNTX has increased by 4.57%, indicating upward momentum in the market. This volume is 32.92% above the average 50 day volume. Yesterday the company had a press release: Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76. |
| CTMX | 1.56% | CYTOMX THERAPEUTICS INC's (NASDAQ:CTMX) traded a high volume of 8.48M shares. NASDAQ:CTMX is experiencing an advancement of 1.56% in its share price today. The current trading volume is 52.37% above the average 50-day volume. This indicates a significant deviation from the average trading activity. |
| EBS | 16.97% | 12.57M shares of EMERGENT BIOSOLUTIONS INC (NYSE:EBS) have been traded so far today. Leading to a price increase of 16.97%. The average daily volume over 50 days is 4.94M, so this is 154.0% above the average volume. Two days ago the company had a press release: Emergent BioSolutions Reports First Quarter 2024 Financial Results. |
| GV | -4.0% | VISIONARY HOLDINGS INC (NASDAQ:GV) has an unusual volume of 177.67K shares today. The price of NASDAQ:GV is experiencing a downturn, with a decrease of 4.0%. With an average daily volume of 136.07K over the past 50 days, today's volume is 30.57% above the average, indicating a potential shift in market sentiment. |
| NUWE | -13.5% | NUWELLIS INC (NASDAQ:NUWE) has an unusual volume of 8.86M shares. The share price decreased by 13.5%. This volume is 194.0% above the average 50 day volume. |
| SNSE | 0.0% | SENSEI BIOTHERAPEUTICS INC (NASDAQ:SNSE) has an unusual volume of 444.6K shares. The average daily volume over the past 50 days is 178.19K. Hence, the current volume is 150.0% above the average volume, indicating a deviation from the usual trading pattern. |
| FLJ | -13.12% | Today's trading session witnessed an unusual volume of 212.53K shares for FLJ GROUP LTD-ADR (NASDAQ:FLJ). NASDAQ:FLJ is experiencing a downward trend, with a decline of 13.12%. The average daily volume over the past 50 days is 119.08K. Hence, the current volume is 78.48% above the average volume, indicating a deviation from the usual trading pattern. |
| RGF | 21.76% | REAL GOOD FOOD CO INC/THE (NASDAQ:RGF) has an unusual volume of 2.39M shares today. The share price of NASDAQ:RGF increased by 21.76% today, reflecting positive market movement. The current trading volume is 225.0% above the average 50-day volume. This indicates a significant deviation from the average trading activity. A press release (The Real Good Food Company Appoints New Senior Food Executives to Lead Finance, Procurement, Supply Chain and Business Management) was released two days ago. |
For the full unusual volume stocks list go to our unusual volume stocks screener.
CYTOMX THERAPEUTICS INC
NASDAQ:CTMX (5/17/2024, 7:00:01 PM)
After market: 1.8994 +0.01 (+0.5%)1.89
-0.11 (-5.5%)
CTMX News
SOUTH SAN FRANCISCO, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally...
3 days ago - USA News GroupBiotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection/PRNewswire/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood...
3 days ago - USA News GroupBiotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...
9 days ago - ChartmillWhat's going on in today's sessionTop movers analysis one hour before the close of the markets on 2024-05-09: top gainers and losers in today's session.
9 days ago - InvestorPlaceSOUN Stock Alert: SoundHound AI Announces New Partnership With PerplexitySoundHound AI stock is slipping on Thursday as SOUN investors appear unimpressed by a new LLM collaboration with Perplexity.
9 days ago - InvestorPlaceDear NVDA Stock Fans, Mark Your Calendars for June 2Nvidia stock fans will want to keep an eye on the tech company when June 2 rolls around for a potential catalyst for NVDA shares.
9 days ago - ChartmillLet's take a look at the stocks that are in motion in today's session.Which stocks are experiencing notable movement on Thursday?
9 days ago - InvestorPlaceWhy Is CytomX (CTMX) Stock Down 43% Today?CytomX Therapeutics stock is falling hard on Thursday after the company posted lackluster results in a cancer treatment clinical trial update.
9 days ago - ChartmillGapping stocks in Thursday's sessionThe market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
9 days ago - ChartmillThursday's pre-market session: top gainers and losersCurious about the stocks that are showing activity before the opening bell on Thursday?
9 days ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayPre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!
10 days ago - InvestorPlaceCTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q1 2024CTMX stock results show that CytomX Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
